Skip to content

The effect of taking calcium and vitamin D on the rate af recurrence and severity of benign paroxysmal positional vertigo

The effect of taking calcium and vitamin D on the rate af recurrence and severity of benign paroxysmal positional vertigo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170505033824N1
Enrollment
86
Registered
2019-08-02
Start date
2018-12-30
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign paroxysmal vertigo. Disorders of vestibular function

Interventions

Intervention 1: Intervention group: After hallpike test and after training on drug consumption patients will be treated with betahistine 8mg three times a day (for 10 days) and vitamin D 50000 unit (p

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of peripheral vestibular lesions and proper cognition according to Hallpik test

Exclusion criteria

Exclusion criteria: Central lesions like stroke, Parkinson's disease, brain trauma according to a neurologist's diagnosis or history of psychiatric diseases or deformities that impair the balance, such as severe spinal deviation or deformity of the lower extremities Addict and alcoholic people and pregnant women, as well as those who are not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Severity of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.;Duration of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.;Rate of recorrence of vertigo. Timepoint: before intervention - after intervention (3 month). Method of measurement: VAS criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Motamedi

Birjand University of Medical Sciences

Hadi.motamedi92@gmail.com+98 56 3239 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026